Koya Medical Secures $26M in Series B Funding, Led by 3x5 Partners

3x5 Partners, a venture capital firm focused on investing in solutions that respond to global healthcare and climate needs, led a $26 million Series B funding transaction for Koya Medical. Koya Medical is a healthcare company determined to impact treatments for lymphedema, a painful condition caused by blockage of the lymphatic system. Faegre Drinker guided 3x5 Partners in the transaction, which is funding Koya Medical's plans to accelerate the expansion and commercialization of its Dayspring active compression system, the first active compression treatment enabling movement and mobility that is cleared by the U.S. Food and Drug administration.